MoneyWorks4Me

Sequent Scientific informs about change in directorate

15 Jan 2022 Evaluate
Sequent Scientific has informed that the Board of Directors of the Company has taken on record/ approved the following changes in the composition of the Board of Directors at its meeting held on January 14, 2022: Manish Gupta (DIN: 06805265) - Resigned as a Managing Director and Chief Executive Officer (MD & CEO) of the Company with effect from April 10, 2022; Rajaram Narayanan (DIN: 02977405) - Appointed as MD & CEO of the Company for a period of 5 years, with effect from April 11, 2022. The appointment is subject to the approval of shareholders of the Company, which shall be sought separately.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1849.60
Dr. Reddys Labs. 1211.70
Cipla 1381.75
Lupin 2117.40
Zydus Lifesciences 1164.25
View more..